| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.8 |